How Is The Market Feeling About Moderna?
Portfolio Pulse from Benzinga Insights
Moderna's (NYSE:MRNA) short interest has decreased by 3.53% since the last report, with 21.44 million shares sold short, representing 7.38% of its float. This decline in short interest could indicate a more bullish sentiment towards MRNA among traders. The current short interest is higher than the peer group average of 5.01%, suggesting Moderna is more heavily shorted compared to its peers.
April 25, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The decrease in short interest for Moderna suggests a potential increase in bullish sentiment among investors, possibly leading to short-term positive price movement.
A decrease in short interest typically indicates that fewer investors are betting on the stock's decline, which can lead to a reduction in selling pressure and potentially result in a price increase. Given Moderna's higher than average short interest compared to peers, this decrease is particularly noteworthy and could signal a short-term positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90